226 related articles for article (PubMed ID: 35625865)
1.
Dikeocha IJ; Al-Kabsi AM; Chiu HT; Alshawsh MA
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625865
[No Abstract] [Full Text] [Related]
2. Investigation into the Potential Role of
Dikeocha IJ; Al-Kabsi AM; Ahmeda AF; Mathai M; Alshawsh MA
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175785
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
4. Prophylactic
Lapiere A; Geiger M; Robert V; Demarquay C; Auger S; Chadi S; Benadjaoud M; Fernandes G; Milliat F; Langella P; Benderitter M; Chatel JM; Sémont A
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 32985332
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the relative abundance of
Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
[No Abstract] [Full Text] [Related]
6. Action and function of Faecalibacterium prausnitzii in health and disease.
Ferreira-Halder CV; Faria AVS; Andrade SS
Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907
[TBL] [Abstract][Full Text] [Related]
7. Co-Culture with
Kim H; Jeong Y; Kang S; You HJ; Ji GE
Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189
[No Abstract] [Full Text] [Related]
8. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
[TBL] [Abstract][Full Text] [Related]
9. Functional Characterization of Novel
Martín R; Miquel S; Benevides L; Bridonneau C; Robert V; Hudault S; Chain F; Berteau O; Azevedo V; Chatel JM; Sokol H; Bermúdez-Humarán LG; Thomas M; Langella P
Front Microbiol; 2017; 8():1226. PubMed ID: 28713353
[No Abstract] [Full Text] [Related]
10. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
Ganesan K; Chung SK; Vanamala J; Xu B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
[TBL] [Abstract][Full Text] [Related]
11. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
Qiu X; Zhang M; Yang X; Hong N; Yu C
J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
[TBL] [Abstract][Full Text] [Related]
12. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis.
Zhou Y; Xu H; Xu J; Guo X; Zhao H; Chen Y; Zhou Y; Nie Y
AMB Express; 2021 Feb; 11(1):33. PubMed ID: 33641084
[TBL] [Abstract][Full Text] [Related]
13. Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer.
Touchefeu Y; Duchalais E; Bruley des Varannes S; Alameddine J; Mirallie E; Matysiak-Budnik T; Le Bastard Q; Javaudin F; Rimbert M; Jotereau F; Montassier E
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):149-156. PubMed ID: 32675782
[TBL] [Abstract][Full Text] [Related]
14. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
[TBL] [Abstract][Full Text] [Related]
15.
Shin JH; Lee Y; Song EJ; Lee D; Jang SY; Byeon HR; Hong MG; Lee SN; Kim HJ; Seo JG; Jun DW; Nam YD
Front Microbiol; 2023; 14():1123547. PubMed ID: 37007480
[TBL] [Abstract][Full Text] [Related]
16. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
[TBL] [Abstract][Full Text] [Related]
17.
Carasi P; Racedo SM; Jacquot C; Elie AM; Serradell ML; Urdaci MC
Front Immunol; 2017; 8():88. PubMed ID: 28239378
[No Abstract] [Full Text] [Related]
18. Both living and dead Faecalibacterium prausnitzii alleviate house dust mite-induced allergic asthma through the modulation of gut microbiota and short-chain fatty acid production.
Hu W; Lu W; Li L; Zhang H; Lee YK; Chen W; Zhao J
J Sci Food Agric; 2021 Oct; 101(13):5563-5573. PubMed ID: 33709404
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
20. Immunomagnetic Capture of Faecalibacterium prausnitzii Selectively Modifies the Fecal Microbiota and Its Immunomodulatory Profile.
Marcos-Fernández R; Riestra S; Alonso-Arias R; Ruiz L; Sánchez B; Margolles A
Microbiol Spectr; 2023 Feb; 11(1):e0181722. PubMed ID: 36598219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
